Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Articles

Page Path
HOME > Cancer Res Treat > Volume 49(1); 2017 > Article
Original Article Risk Factors for Thyroid Cancer: A Hospital-Based Case-Control Study in Korean Adults
Seung-Kwon Myung, MD, PhD1,2,3,4, Chan Wha Lee, MD2,5,, Jeonghee Lee, MS4, Jeongseon Kim, PhD1,4,, Hyeon Suk Kim, PhD6
Cancer Research and Treatment : Official Journal of Korean Cancer Association 2017;49(1):70-78.
DOI: https://doi.org/10.4143/crt.2015.310
Published online: June 23, 2016

1Department of Cancer Control and Policy, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea

2Center for Cancer Prevention and Detection, National Cancer Center Hospital, National Cancer Center, Goyang, Korea

3Department of Family Medicine, National Cancer Center Hospital, National Cancer Center, Goyang, Korea

4Molecular Epidemiology Branch, Research Institute, National Cancer Center, Goyang, Korea

5Department of Radiology, Center for Diagnostic Oncology, National Cancer Center Hospital, National Cancer Center, Goyang Korea

6School of Nursing, Shinhan University, Dongducheon, Korea

Correspondence: Chan Wha Lee, MD  Department of Radiology, Center for Diagnostic Oncology, National Cancer Center Hospital, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Korea 
Tel: 82-31-920-2639 Fax: 82-31-920-2606 E-mail: cwlee@ncc.re.kr
Co-Correspondence: Jeongseon Kim, PhD  Department of Cancer Control and Policy, Graduate School of Cancer Science and Policy, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Korea 
Tel: 82-31-920-2570 Fax: 82-31-920-2579 E-mail: jskim@ncc.re.kr
• Received: August 17, 2015   • Accepted: June 6, 2016

Copyright © 2017 by the Korean Cancer Association

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 15,108 Views
  • 442 Download
  • 51 Web of Science
  • 47 Crossref
  • 56 Scopus
prev next
  • Purpose
    Although the incidence of thyroid cancer in Korea has rapidly increased over the past decade, few studies have investigated its risk factors. This study examined the risk factors for thyroid cancer in Korean adults.
  • Materials and Methods
    The study design was a hospital-based case-control study. Between August 2002 and December 2011, a total of 802 thyroid cancer cases out of 34,211 patients screened from the Cancer Screenee. Cohort of the National Cancer Center in South Korea were included in the analysis. A total of 802 control cases were selected from the same cohort, and matched individually (1:1) by age (±2 years) and area of residence for control group 1 and additionally by sex for control group 2.
  • Results
    Multivariate conditional logistic regression analysis using the control group 1 showed that females and those with a family history of thyroid cancer had an increased risk of thyroid cancer, whereas ever-smokers and those with a higher monthly household income had a decreased risk of thyroid cancer. On the other hand, the analysis using control group 2 showed that a family history of cancer and alcohol consumption were associated with a decreased risk of thyroid cancer, whereas higher body mass index (BMI) and family history of thyroid cancer were associated with an increased risk of thyroid cancer.
  • Conclusion
    These findings suggest that females, those with a family history of thyroid cancer, those with a higher BMI, non-smokers, non-drinkers, and those with a lower monthly household income have an increased risk of developing thyroid cancer.
According to the World Cancer Report 2014, thyroid cancer is one of the less frequent cancers worldwide [1]. Its incidence, however, has increased almost two-fold over the past few decades, due mainly to the increased detection of thyroid cancer using thyroid ultrasonography [1,2]. In particular, the incidence rate of thyroid cancer in South Korea in 2011 was 15 times higher than in 1993 [3].
Although the precise causes of thyroid cancer remain unclear, a few risk factors, such as exposure to radiation, sex (women), and a diet low in iodine (follicular thyroid cancer) are known to increase the risk of thyroid cancer [4]. Recently, several lifestyle factors have been suggested to have an association with the risk of developing thyroid cancer from the findings of observational studies. According to Schmid et al.’s meta-analysis [5] of case-control and cohort studies in 2013, there was no overall significant association between physical activity and thyroid cancers, even though subgroup analyses revealed inconsistent findings according to the study design. In 2012, Zhao et al. [6] reported that overweight and obesity increased the risk of thyroid cancer significantly (by 18%) from the findings of a meta-analysis of seven cohort studies. On the contrary, unlike other cancers, a pooled analysis of five prospective studies in the United States suggested that cigarette smoking and alcohol consumption were associated with a decreased risk of thyroid cancer [7]. In addition, Cho and Kim [8] reported that the risk of thyroid cancer was decreased by 21% in ever-smokers compared to never-smokers when they performed a meta-analysis of 31 observational studies [8].
As described before, the age-standardized incidence of thyroid cancer in Korea women (88.6 per 100,000) has increased rapidly and is the highest among all countries in the world (20 per 100,000 for the United States, 12.7 for Australia, and 6.1 per 100,000 for world) [9]. Despite this, few studies have reported the risk factors for thyroid cancer in Korean adults. Moreover, the sample sizes of previous case-control studies on this issue were small.
This study examined the risk factors for thyroid cancer in Korean adults using a hospital-based case-control study.
1. Study population
A large hospital-based case-control study was conducted using the data from the Cancer Screenee Cohort of the National Cancer Center in South Korea. All participants were men and women aged between 30 and 70 years, who underwent health screening examinations including thyroid ultrasonography. All the participants were asked to complete a self-administered questionnaire about their sociodemographic characteristics (e.g., age, education, occupation, household income, and marital status), cigarette smoking habits, alcohol drinking habits, and their regular exercise habits. A total of 34,211 participants provided written informed consent for study participation between August 2002 and December 2011.
2. Case and control selection
The thyroid cancer cases were defined based on the International Classification of Diseases for Oncology (ICD-O) (code C73) and were ascertained by a linkage to the Korea Central Cancer Registry (KCCR) database, which has been used to identify the incidence of cancer in Korea. Among the 828 thyroid cancer patients, a total of 802 patients were finally selected after excluding those who did not answer the questionnaire.
The controls were selected from the same cohort with 34,211 participants, who underwent health screening examinations including thyroid ultrasonography. Among the potential controls (n=31,453) who were not diagnosed with any cancer including thyroid cancer, 2,962 participants were excluded due to missing questionnaires or insufficient information on their residential areas. From the remaining 28,491 participants, using an incidence density sampling method, one control was selected randomly for each thyroid cancer case from the appropriate risk sets consisting of all study participants, free of cancer. Those in control group 1 were matched individually to the cases according to age (within 2 years) and residential area (Seoul, Gyeonggi, Gangwon, Chungcheong, Jeolla, Gyeongsang, Jeju, North America, and other Asian countries). In control group 1, sex was not included as a matching variable to determine if sex is associated with the risk of thyroid cancer. In addition, the controls for control group 2 were matched to cases by age (within 2 years), residential areas Seoul, Gyeonggi, Gangwon, Chungcheong, Jeolla, Gyeongsang, Jeju, North America, and other Asian countries), and also sex to reduce the confounding effect of sex. A total of 802 incident cases and 802 controls were included for the final analysis. The study procedure including the linkage to the KCCR database was approved by the institutional review board of the National Cancer Center (NCC2014-0096).
3. Statistical methods
To assess the association between the risk factors and thyroid cancer, conditional logistic regression models were used to calculate the odds ratios (ORs) and 95% confidence intervals (CIs) using univariate and multivariate analyses. The multivariate conditional logistic regression models were adjusted for sex (female vs. male), body mass index (BMI, kg/m2: < 23, 23-25, ≥ 25), family history of cancer (first degree relative: yes vs. no), family history of thyroid cancer (first degree relative: yes vs. no), education (college or above, high school vs. middle school or below), occupation (agriculture/laborer/unemployed/others, sales/service, profession/office worker vs. housewife), monthly household income (> $3,706 or $1,853-$3,706 vs. < $1,853), marital status (divorced/widowed, unmarried vs. married), alcohol consumption (ever-drinker, current drinker, former drinker vs. non-drinker), and smoking status (ever-smoker, current smoker, former smoker vs. non-smoker). In addition, the Cochran-Armitage test for trend was conducted to investigate the relationship between increasing exposure to smoking and thyroid cancer risk. All the analyses were performed for both control groups 1 and 2. The goodness of fit of a model was measured by the generalized R2 statistic that Allison discussed [10] as follows:
R2=1-e-(LRT/n)
, where likelihood ratio test statistic (LRT)=–2logL(0)– [–2logL(p)], n is the sample size, logL(0) is the log-likelihood for a null model with no covariates, and logL(p) is the log-likelihood for the fitted model with p covariates. All statistical analyses were performed using SAS ver. 9.3 software (SAS Institute Inc., Cary, NC).
Table 1 lists the distribution of the general characteristics among the 1,604 participants with thyroid cancer (n=802) and control cases (n=802) in the control group 1 according to sex, BMI, family history of cancer, family history of thyroid cancer, education, occupation, monthly household income, marital status, alcohol consumption, and smoking status. In univariate analysis, females (OR, 2.97; 95% CI, 2.38 to 3.71), family history of thyroid cancer (OR, 3.64; 95% CI, 1.87 to 7.09), and divorced or widowed (OR, 2.38; 95% CI, 1.54 to 3.67) were associated with an increased risk of thyroid cancer, whereas a family history of cancer, higher education levels, other occupations (other than housewife), higher monthly household incomes, alcohol consumption, and ever-smokers were associated with a decreased risk of thyroid cancer (Table 1).
Table 1 also lists the findings from multivariate conditional logistic regression analysis adjusted for sex, BMI, family history of cancer, family history of thyroid cancer, education, occupation, monthly household income, marital status, alcohol consumption, and smoking status. The results showed that females (OR, 2.08; 95% CI, 1.26 to 3.45) and a family history of thyroid cancer (OR, 4.39; 95% CI, 1.73 to 11.15) were more likely to have an increased risk of thyroid cancer, whereas higher household incomes (> $3,706 vs. < $1,853; OR, 0.59; 95% CI, 0.36 to 0.98) and ever-smokers (OR, 0.62; 95% CI, 0.44 to 0.86) were more likely to have a decreased risk of thyroid cancer. On the other hand, there was no significant association observed with BMI, family history of cancer, education levels, occupational, marital status, and alcohol consumption.
In multivariate conditional logistic regression analysis according to the smoking history, compared to non-smokers, there was a dose-response relationship in the ever-smokers between the years of cigarette smoking and a decreased risk of thyroid cancer (OR, 0.87; 95% CI, 0.50 to 1.50 for ≤ 10 years; OR, 0.61; 95% CI, 0.39 to 0.95 for 11-20 years; OR, 0.59; 95% CI, 0.37 to 0.95 for 21-30 years; OR, 0.62; 95% CI, 0.35 to 1.10 for > 30 years; p-value for trend=0.019) (Table 2). On the other hand, no dose-response relationship was observed for the age when they started to smoke and the number of daily cigarette smoking.
Table 3 lists the general characteristics of the study participants with the same case group and the control group 2 in univariate analysis and multivariate conditional logistic regression analysis. In multivariate conditional logistic regression analysis, a family history of cancer and alcohol consumption were associated with a decreased risk of thyroid cancer, whereas a higher BMI and a family history of thyroid cancer were associated with an increased risk of thyroid cancer. Unlike the findings from multivariate analysis using control group 1, smoking was not associated with a risk of thyroid cancer.
This hospital-based case-control study found that females and those with a family history of thyroid cancer had an increased risk of thyroid cancer. In contrast, ever-smokers and those with higher household incomes were more likely to have a lower risk of thyroid cancer. In particular, an inverse dose-response association was observed between the years of cigarette smoking and the thyroid cancer risk. When the analysis was performed using the control group matched by sex as well as age and residential areas, alcohol consumption was significantly associated with a decreased risk of thyroid cancer.
Overall, these findings are consistent with those of previous studies and reports on the general characteristics and risk factors of thyroid cancer. According to the GLOBOCAN 2012 of the International Agency of Research on Cancer, the age-standardized incidence rate of thyroid cancer worldwide was approximately 3.2 times higher in women than in men: 6.1 per 100,000 and 1.9 per 100,000, respectively [11]. In addition, the incidence data obtained from the Korea National Cancer Incidence Database showed that age-standardized incidence rates per 100,000 were 102.4 in women and 23.0 in men [12], which were approximately 4.5 times higher in women than in men. These results show that thyroid cancer is 3-4 times more common in women than in men. This study also showed that the risk of thyroid cancer was more than 2 times higher in women than in men.
The reasons for the difference in incidence between men and women is unclear. However, estrogen, which is one of the two main female sex hormones, might explain the sex difference in the incidence of thyroid cancer. Several studies have shown that the estrogen levels might be associated with the risk of thyroid cancer. For example, although the frequency of differentiated thyroid cancer (papillary or parafollicular thyroid cancer) in girls was similar to that in boys up to the age of 12 years, with the onset of puberty, it increased in girls [13]. In addition, pregnancy was associated with an increased risk of thyroid cancer [14,15]. The onset of puberty and pregnancy are associated with increased levels of estrogen. In contrast, the incidence of thyroid cancer was highest in the late 40s and early 50s (perimenopause) and decreased thereafter (postmenopause) [12]. During these periods, the estrogen levels start to decrease rapidly and level off. As a potential mechanism for the impact of estrogen on the increased risk of thyroid cancer, several experimental studies have shown that 17β-estradiol (E2, predominant estrogen during reproductive periods) is a potent stimulating agent of both benign and malignant thyroid cells [16-18]. E2 acts via a classical genomic pathway mediated through the estrogen receptors α and β (ERα and ERβ) and a non-genomic pathway by membrane-associated estrogen receptor [19]. Both pathways are operative in benign and malignant thyroid tissues, even though the detection of ERs in normal thyroid tissues, thyroid adenomas, goiters, and thyroid carcinomas by immunohistochemical staining or reverse transcription polymerase chain reaction varies between 0% and 100% of samples [18,19]. Nevertheless, the influence of estrogen on the development of thyroid cancer is still unclear. Further detailed studies will be necessary to confirm the association between estrogen and thyroid cancer.
A family history of thyroid cancer was also found to be associated with an increased risk of thyroid cancer. The increased risk of differentiated thyroid cancer was associated with a family history of thyroid cancer from the previous observational studies [20]. In addition, a recent population-based cohort study with 63,495 first-degree relatives of 11,206 non-medullary thyroid cancer patients reported a three-fold increase over the general population risk (standardized incidence ratio, 2.9; 95% CI, 2.4 to 3.4) [21].
Interestingly, in contrast to most of common cancers, this study showed that smoking was associated with a decreased risk of thyroid cancer (ever-smoker vs. non-smoker; OR, 0.62; 95% CI, 0.44 to 0.86). This finding is consistent with those from previous meta-analyses of case-control studies. In 2003, a pooled analysis of 14 case-control studies reported a reduced risk of thyroid cancer in current smokers [22]. In addition, a recent meta-analysis published in 2014 demonstrated an inverse association in subgroup meta-analysis of case-control studies (ever-smoker vs. non-smoker; OR, 0.79; 95% CI, 0.70 to 0.88) [8]. Similarly, in a pooled analysis of five prospective studies, smoking was associated with a lower risk of thyroid cancer in current smokers compared to never smokers (HR, 0.68; 95% CI, 0.55 to 0.85) [7].
Several potential biological mechanisms have been suggested to explain the reduced risk of thyroid cancer in smokers. First, smoking can lead to lower levels of thyroid stimulating hormone (TSH), which plays an important role in the development of thyroid cancer [23]. Second, smoking has an anti-estrogenic effect, which can result in a reduced risk of thyroid cancer [19]. Finally, smokers are less likely to be overweight or obese, which might be associated with an increased risk of thyroid cancer. In 2012, a meta-analysis of seven cohort studies found that overweight and obesity were linked to an 18% increased risk of thyroid cancer in men and women [6].
In the present findings, higher household incomes were more likely to have a decreased risk of thyroid cancer (> $3,706 vs. < $1,853; OR, 0.59; 95% CI, 0.36 to 0.98). On the other hand, previous studies have reported that higher socioeconomic status (SES) groups were more likely to show an increased risk of thyroid cancer compared to lower SES groups in the United States [24]. In particular, the incidence of thyroid cancer showed a less pronounced increase in low SES groups (6.7% per year) than that in the high SES groups (8.6% per year) in the United States. White Americans showed a steady increase in both the low and high SES groups, while African-Americans and Hispanics with a higher SES showed a more noticeable increase compared to the lower SES groups from 1995 to 2008 [24]. This issue may reflect the limitation in accessing health care services in low SES groups and minorities due to the low health insurance coverage [24]. This discrepancy cannot be explained at present; therefore, further studies will be required.
Additionally, alcohol consumption was found to be significantly associated with a decreased risk of thyroid cancer when the analysis was performed using the control group matched by sex as well as age and residential areas. This finding is consistent with those from the previous pooled analysis of five cohort studies published in 2012 [7]. The possible biological mechanisms include decreased levels of TSH and the direct toxic effects of alcohol consumption [25,26].
This study has several limitations. First, the thyroid cancer cases were not confirmed based on the medical records and chart reviews. The thyroid cancer cases were ascertained by a linkage to the KCCR database based on the ICD-O (code C73), which may lead to ascertainment bias. Therefore, the specific type of thyroid cancer could not be defined in each case. On the other hand, it would be reasonable to assume that most of the cases included in the present study were papillary thyroid cancers because 94.2% of all incident thyroid cancers from 1997 to 2011 were papillary thyroid cancer according to the Korea National Cancer Incidence Database [27]. Second, the controls were also not confirmed from their medical records and chart reviews. On the other hand, the possibility of ascertainment bias might be minimal, if any, because the KCCR database covers almost all incident cancer cases, including thyroid cancer nationwide in Korea. Therefore, there would be little likelihood of the thyroid cancer cases being included in the control group of this study. Third, due to a lack of data, this study was unable to investigate the influence of previous exposure to radiation on thyroid cancer, which is a proven risk factor for thyroid cancer. Finally, recall bias might still exist as some data were collected retrospectively. In addition, these findings might not be applicable to the general population because the participants included in this study were recruited from one specific hospital screening center.
To the best of the authors’ knowledge, this is the second largest case-control study on the risk factors of thyroid cancer since Kreiger and Parkes’s study in 2000 [28]. Therefore, this study provides more precision on this issue than most previous individual studies.
This hospital-based case-control study found that females, higher BMI, and those with a family history of thyroid cancer were significantly associated with an increased risk of thyroid cancer, whereas ever-smokers, drinkers, and those with higher household incomes were associated with a decreased risk of thyroid cancer. Nevertheless, these findings should be explored in further larger epidemiological studies with a higher level of evidence, such as prospective cohort studies.

Conflict of interest relevant to this article was not reported.

Acknowledgements
This work was supported by grants from the National Research Foundation of Korea (NRF-2015R1D1A1A09058684) and from the National Cancer Center of Korea (NCC1510040).
Table 1.
General characteristics of the study participants with the control group 1 in univariate analysis and multivariate conditional logistic regression analysis
Variable Controla) (n=802) Case (n=802) Crude OR (95% CI) Adjusted OR (95% CI)b)
Sex
 Male 432 (53.9) 229 (28.6) 1.00 1.00
 Female 370 (46.1) 573 (71.5) 2.97 (2.38-3.71) 2.08 (1.26-3.45)
BMI (kg/m2)
 < 23 307 (38.3) 309 (38.5) 1.00 1.00
 23-25 218 (27.2) 221 (27.6) 1.01 (0.79-1.29) 1.21 (0.85-1.72)
 > 25 277 (34.5) 272 (33.9) 0.98 (0.77-1.23) 1.23 (0.88-1.72)
Family history of cancerc)
 No 211 (26.3) 246 (30.7) 1.00 1.00
 Yes 585 (72.9) 543 (67.7) 0.79 (0.63-0.99) 0.74 (0.54-1.02)
 Missing 6 (0.8) 13 (1.6)
Family history of thyroid cancerc)
 No 785 (97.9) 748 (93.3) 1.00 1.00
 Yes 11 (1.4) 41 (5.1) 3.64 (1.87-7.09) 4.39 (1.73-11.15)
 Missing 6 (0.8) 13 (1.6)
Education
 Middle school or below 121 (15.1) 139 (17.3) 1.00 1.00
 High school 263 (32.8) 260 (32.4) 0.82 (0.60-1.12) 1.06 (0.66-1.69)
 College or above 409 (51.0) 350 (43.6) 0.67 (0.49-0.92) 1.19 (0.72-1.97)
 Missing 9 (1.1) 53 (6.6)
Occupation
 Housewife 228 (28.4) 349 (43.5) 1.00 1.00
 Profession/Office worker 329 (41.0) 229 (28.6) 0.46 (0.36-0.59) 1.11 (0.26-1.76)
 Sales/Service 122 (15.2) 100 (12.5) 0.55 (0.40-0.76) 1.07 (0.66-1.71)
 Agriculture/Laborer/Unemployed/Others 114 (14.2) 80 (10.0) 0.47 (0.32-0.66) 0.99 (0.56-1.76)
 Missing 9 (1.1) 44 (5.5)
Monthly household income
 < $1,853d) 82 (10.2) 107 (13.3) 1.00 1.00
 $1,853-$3,706 221 (27.6) 224 (27.9) 0.65 (0.44-0.97) 0.72 (0.44-1.19)
 > $3,706 429 (53.5) 329 (41.0) 0.49 (0.33-0.71) 0.59 (0.36-0.98)
 Missing 70 (8.7) 142 (17.7)
Marital status
 Married 741 (92.4) 674 (84.0) 1.00 1.00
 Unmarried 26 (3.2) 25 (3.1) 1.01 (0.55-1.87) 0.70 (0.31-1.62)
 Divorced/Widowed 35 (4.4) 74 (9.2) 2.38 (1.54-3.67) 1.67 (0.87-3.22)
 Missing 0 29 (3.6)
Alcohol consumption
 Non-drinker 236 (29.4) 360 (44.9) 1.00 1.00
 Former drinker 30 (3.7) 45 (5.6) 1.05 (0.63-1.76) 1.79 (0.87-3.71)
 Current drinker 520 (64.8) 373 (46.5) 0.46 (0.36-0.57) 0.92 (0.66-1.30)
 Ever-drinker 550 (49.0) 418 (25.7) 0.50 (0.40-0.61) 0.81 (0.63-1.06)
 Missing 16 (2.0) 24 (3.0)
Smoking status
 Non-smoker 382 (47.6) 547 (68.2) 1.00 1.00
 Former smoker 178 (22.2) 109 (13.6) 0.43 (0.33-0.58) 0.75 (0.48-1.17)
 Current smoker 215 (26.8) 97 (12.1) 0.29 (0.22-0.40) 0.49 (0.31-0.78)
 Ever-smoker 393 (49.0) 206 (25.7) 0.34 (0.27-0.43) 0.62 (0.44-0.86)
 Missing 27 (3.4) 49 (6.1)

OR, odds ratio; CI, confidence interval; BMI, body mass index.

a) Matched to cases by age (within 2 years) and residential areas,

b) Adjusted for BMI, family history of cancer, family history of thyroid cancer, education, occupation, monthly household income, marital status, alcohol consumption, and smoking status; R2=0.1277,

c) First degree relatives,

d) $1=1,079 Korean won (as of April 26, 2015).

Table 2.
Association between the risk of thyroid cancer and smoking history, such as age at starting to smoke, years of cigarette smoking, and number of daily cigarette smoking in multivariate conditional logistic regression analysis
Variable Control (n=802) Case (n=802) Crude OR (95% CI) Adjusted OR (95% CI)a)
Age at starting to smoke
 Never smoking 382 (47.6) 547 (68.2) 1.00 1.00
 ≤ 18 74 (9.2) 31 (3.9) 0.26 (0.17-0.42) 0.52 (0.29-0.93)
 19-24 223 (27.8) 121 (15.1) 0.36 (0.28-0.48) 0.76 (0.52-1.12)
 ≥ 25 54 (6.7) 28 (3.5) 0.38 (0.23-0.62) 0.57 (0.33-1.01)
 Missing 69 (8.6) 75 (9.4)
 p-value for trend < 0.001 0.133
Years of cigarette smoking
 Never smoking 382 (47.6) 547 (68.2) 1.00 1.00
 ≤ 10 40 (5.0) 34 (4.2) 0.60 (0.37-0.99) 0.87 (0.50-1.50)
 11-20 122 (15.2) 58 (7.2) 0.33 (0.23-0.47) 0.61 (0.39-0.95)
 21-30 128 (16.0) 62 (7.7) 0.30 (0.20-0.43) 0.59 (0.37-0.95)
 > 30 71 (8.9) 29 (3.6) 0.29 (0.18-0.47) 0.62 (0.35-1.10)
 Missing 59 (7.4) 72 (9.0)
 p-value for trend < 0.001 0.019
No. of cigarettes/day
 Never smoking 382 (47.6) 547 (68.2) 1.00 1.00
 ≤ 10 110 (13.7) 58 (7.2) 0.35 (0.25-0.50) 0.61 (0.40-0.93)
 11-20 180 (22.4) 101 (12.6) 0.39 (0.29-0.52) 0.84 (0.56-1.26)
 21-30 48 (6.0) 16 (2.0) 0.23 (0.12-0.41) 0.42 (0.22-0.82)
 > 30 25 (3.1) 11 (1.4) 0.27 (0.13-0.56) 0.61 (0.26-1.42)
 Missing 57 (7.1) 69 (8.6)
 p-value for trend < 0.001 0.071

OR, odds ratio; CI, confidence interval.

a) Adjusted for sex, body mass index, family history of cancer, family history of thyroid cancer, education, occupation, monthly household income, marital status, smoking status, and alcohol consumption; R2=0.1070.

Table 3.
General characteristics of the study participants with the control group 2 in univariate analysis and multivariate conditional logistic regression analysis
Variable Controla) (n=802) Case (n=802) Crude OR (95% CI) Adjusted OR (95% CI)b)
Sex
 Male 229 (28.6) 229 (28.6) - -
 Female 573 (71.5) 573 (71.5) - -
BMI (kg/m2)
 < 23 353 (44.0) 309 (38.5) 1.00 1.00
 23-25 225 (28.1) 221 (27.6) 1.14 (0.89-1.46) 1.28 (0.98-1.68)
 > 25 224 (27.9) 272 (33.9) 1.11 (1.11-1.80) 1.42 (1.09-1.85)
Family history of cancerc)
 No 187 (23.3) 246 (30.7) 1.00 1.00
 Yes 606 (75.6) 543 (67.7) 0.66 (0.52-0.83) 0.63 (0.49-0.81)
 Missing 9 (1.1) 13 (1.6)
Family history of thyroid cancerc)
 No 787 (98.1) 748 (93.3) 1.00 1.00
 Yes 6 (0.8) 41 (5.1) 8.00 (3.16-20.27) 9.41 (3.61-24.51)
 Missing 9 (1.1) 13 (1.6)
Education
 Middle school or below 159 (19.8) 139 (17.3) 1.00 1.00
 High school 276 (34.4) 260 (32.4) 1.08 (0.80-1.45) 1.19 (0.86-1.66)
 College or above 353 (44.0) 350 (43.6) 1.15 (0.85-1.57) 1.29 (0.90-1.86)
 Missing 14 (1.8) 53 (6.6)
Occupation
 Housewife 344 (42.9) 349 (43.5) 1.00 1.00
 Profession/Office worker 229 (28.6) 229 (28.6) 0.94 (0.70-1.24) 0.87 (0.63-1.20)
 Sales/Service 113 (14.1) 100 (12.5) 0.84 (0.61-1.17) 0.77 (0.53-1.10)
 Agriculture/Laborer/Unemployed/Others 101 (12.6) 80 (10.0) 0.75 (0.53-1.07) 0.69 (0.47-1.02)
 Missing 15 (1.9) 44 (5.5)
Monthly household income
 < $1,853d) 103 (12.8) 107 (13.3) 1.00 1.00
 $1,853-$3,706 215 (26.8) 224 (27.9) 0.99 (0.71-1.38) 0.95 (0.66-1.39)
 > $3,706 389 (48.5) 329 (41.0) 0.79 (0.57-1.08) 0.71 (0.49-1.03)
 Missing 95 (11.9) 142 (17.7)
Marital status
 Married 710 (88.5) 674 (84.0) 1.00 1.00
 Unmarried 20 (2.5) 25 (3.1) 1.33 (0.72-2.44) 1.31 (0.68-2.50)
 Divorced/Widowed 70 (8.7) 74 (9.2) 1.21 (0.84-1.75) 1.25 (0.84-1.86)
 Missing 2 (0.3) 29 (3.6)
Alcohol consumption
 Non-drinker 298 (37.2) 360 (44.9) 1.00 1.00
 Former drinker 34 (4.2) 45 (5.6) 1.06 (0.66-1.71) 1.13 (0.68-1.88)
 Current drinker 455 (56.7) 373 (46.5) 0.61 (0.48-0.78) 0.64 (0.49-0.82)
 Ever-drinker 489 (61.0) 418 (25.7) 1.21 (0.62-2.35) 0.68 (0.53-0.87)
 Missing 15 (1.9) 24 (3.0)
Smoking status
 Non-smoker 541 (67.5) 547 (68.2) 1.00 1.00
 Former smoker 104 (13.0) 109 (13.6) 0.97 (0.66-1.45) 0.97 (0.63-1.48)
 Current smoker 114 (14.2) 97 (12.1) 0.79 (0.55-1.13) 0.82 (0.55-1.22)
 Ever-smoker 218 (27.2) 206 (25.7) 0.86 (0.63-1.19) 0.88 (0.62-1.25)
 Missing 43 (5.4) 49 (6.1)

OR, odds ratio; CI, confidence interval; BMI, body mass index.

a) Matched to cases by age (within 2 years), residential areas, and sex,

b) Adjusted for BMI, family history of cancer, family history of thyroid cancer, education, occupation, monthly household income, marital status, alcohol consumption, and smoking status; R2=0.0711,

c) First degree relatives,

d) $1=1,079 Korean won (as of April 26, 2015).

  • 1. Stewart BW, Wild CP. World cancer report 2014. Lyon: International Agency for Research on Cancer; 2014.
  • 2. Wartofsky L. Increasing world incidence of thyroid cancer: increased detection or higher radiation exposure? Hormones (Athens). 2010;9:103–8. ArticlePubMed
  • 3. Ahn HS, Kim HJ, Welch HG. Korea's thyroid-cancer "epidemic": screening and overdiagnosis. N Engl J Med. 2014;371:1765–7. ArticlePubMed
  • 4. What are the risk factors for thyroid cancer? [Internet]. Atlanta, GA: American Cancer Society; 2015. [cited 2016 May 1]. Available from: http://www.cancer.org/cancer/thyroid-cancer/detailedguide/thyroid-cancer-risk-factors
  • 5. Schmid D, Behrens G, Jochem C, Keimling M, Leitzmann M. Physical activity, diabetes, and risk of thyroid cancer: a systematic review and meta-analysis. Eur J Epidemiol. 2013;28:945–58. ArticlePubMed
  • 6. Zhao ZG, Guo XG, Ba CX, Wang W, Yang YY, Wang J, et al. Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies. J Int Med Res. 2012;40:2041–50. ArticlePubMed
  • 7. Kitahara CM, Linet MS, Beane Freeman LE, Check DP, Church TR, Park Y, et al. Cigarette smoking, alcohol intake, and thyroid cancer risk: a pooled analysis of five prospective studies in the United States. Cancer Causes Control. 2012;23:1615–24. ArticlePubMedPMC
  • 8. Cho YA, Kim J. Thyroid cancer risk and smoking status: a meta-analysis. Cancer Causes Control. 2014;25:1187–95. ArticlePubMed
  • 9. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon: International Agency for Research on Cancer; 2013. [cited 2016 May 1]. Available from: http://globocan.iarc.fr
  • 10. Allison PD. Survival analysis using the SAS: a practical guide. Cary, NC: SAS Institute Inc.; 1995.
  • 11. Thyroid: ASR (W) per 100,000, all ages [Internet]. Lyon: International Agency for Research on Cancer; 2013. [cited 2016 May 1]. Available from: http://globocan.iarc.fr/old/bar_sex_site.asp?selection=27240&title=Thyroid&statistic=2&populations=6&window=1&grid=1&info=1&color1=5&color1e=&color2=4&color2e=&submit=%C2%A0Execute%C2%A0
  • 12. Jung KW, Won YJ, Kong HJ, Oh CM, Cho H, Lee DH, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat. 2015;47:127–41. ArticlePubMedPMCPDF
  • 13. Farahati J, Bucsky P, Parlowsky T, Mader U, Reiners C. Characteristics of differentiated thyroid carcinoma in children and adolescents with respect to age, gender, and histology. Cancer. 1997;80:2156–62. ArticlePubMed
  • 14. Rossing MA, Voigt LF, Wicklund KG, Daling JR. Reproductive factors and risk of papillary thyroid cancer in women. Am J Epidemiol. 2000;151:765–72. ArticlePubMed
  • 15. Horn-Ross PL, Canchola AJ, Ma H, Reynolds P, Bernstein L. Hormonal factors and the risk of papillary thyroid cancer in the California Teachers Study cohort. Cancer Epidemiol Biomarkers Prev. 2011;20:1751–9. ArticlePubMedPMC
  • 16. Zeng Q, Chen GG, Vlantis AC, van Hasselt CA. Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway. Cell Prolif. 2007;40:921–35. ArticlePubMedPMC
  • 17. Kumar A, Klinge CM, Goldstein RE. Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta. Int J Oncol. 2010;36:1067–80. ArticlePubMed
  • 18. Manole D, Schildknecht B, Gosnell B, Adams E, Derwahl M. Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metab. 2001;86:1072–7. ArticlePubMed
  • 19. Derwahl M, Nicula D. Estrogen and its role in thyroid cancer. Endocr Relat Cancer. 2014;21:T273–83. ArticlePubMed
  • 20. Xu L, Li G, Wei Q, El-Naggar AK, Sturgis EM. Family history of cancer and risk of sporadic differentiated thyroid carcinoma. Cancer. 2012;118:1228–35. ArticlePubMedPMC
  • 21. Fallah M, Pukkala E, Tryggvadottir L, Olsen JH, Tretli S, Sundquist K, et al. Risk of thyroid cancer in first-degree relatives of patients with non-medullary thyroid cancer by histology type and age at diagnosis: a joint study from five Nordic countries. J Med Genet. 2013;50:373–82. ArticlePubMed
  • 22. Mack WJ, Preston-Martin S, Dal Maso L, Galanti R, Xiang M, Franceschi S, et al. A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes Control. 2003;14:773–85. ArticlePubMed
  • 23. Jorde R, Sundsfjord J. Serum TSH levels in smokers and non-smokers. The 5th Tromso study. Exp Clin Endocrinol Diabetes. 2006;114:343–7. ArticlePubMed
  • 24. Reitzel LR, Nguyen N, Li N, Xu L, Regan SD, Sturgis EM. Trends in thyroid cancer incidence in Texas from 1995 to 2008 by socioeconomic status and race/ethnicity. Thyroid. 2014;24:556–67. ArticlePubMedPMC
  • 25. Balhara YP, Deb KS. Impact of alcohol use on thyroid function. Indian J Endocrinol Metab. 2013;17:580–7. ArticlePubMedPMC
  • 26. Knudsen N, Bulow I, Laurberg P, Perrild H, Ovesen L, Jorgensen T. Alcohol consumption is associated with reduced prevalence of goitre and solitary thyroid nodules. Clin Endocrinol (Oxf). 2001;55:41–6. ArticlePubMed
  • 27. Oh CM, Jung KW, Won YJ, Shin A, Kong HJ, Lee JS. Age-period-cohort analysis of thyroid cancer incidence in Korea. Cancer Res Treat. 2015;47:362–9. ArticlePubMedPMCPDF
  • 28. Kreiger N, Parkes R. Cigarette smoking and the risk of thyroid cancer. Eur J Cancer. 2000;36:1969–73. ArticlePubMed

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • Narrative overview of possible preventive measures for differentiated thyroid carcinomas
      Maria Eduarda de Castro, Lucas Leite Cunha, Laura Sterian Ward
      Heliyon.2025; 11(1): e41284.     CrossRef
    • Ocular motor cranial neuropathy and risk of thyroid cancer: A Korean population-based study
      Jaeryung Kim, Kyung-Ah Park, Kyungdo Han, Jin-Hyung Jung, Sei Yeul Oh, Soolienah Rhiu, Xing Xiong,
      PLOS ONE.2025; 20(3): e0319872.     CrossRef
    • Nonalcoholic Fatty Liver Disease and the Risk of Thyroid Cancer Among Young Adults in South Korea
      Hyemi Kwon, Kyung-Do Han, Sun Joon Moon, Se Eun Park, Eun-Jung Rhee, Won-Young Lee
      The Journal of Clinical Endocrinology & Metabolism.2024; 109(3): e1095.     CrossRef
    • Current and future of immunotherapy for thyroid cancer based on bibliometrics and clinical trials
      Ke Wang, Ying Zhang, Yang Xing, Hong Wang, Minghua He, Rui Guo
      Discover Oncology.2024;[Epub]     CrossRef
    • Thyroid Cancer Prevalence, Risk Exposure, and Clinical Features Among Transgender Female Veterans
      John David Christensen, Hiba T Basheer, Jose Joaquin Lado Abeal
      Journal of the Endocrine Society.2024;[Epub]     CrossRef
    • Thyroid Malignancy in Patients Who Underwent Thyroidectomy for Multinodular Goiter and Solitary Thyroid Nodule
      Desalew Gedamu, Tariku Shimels, Daniel Kassie, Zewditu Chanyalew, Mebrahtu Eyasu
      JCO Global Oncology.2024;[Epub]     CrossRef
    • Emerging Strategies in Thyroid Cancer Immunotherapy: A Comprehensive Systematic Review and Meta-Analysis of Clinical Outcomes
      Daniel Alejandro Estrella Cornejo, Meylin Yalitza Carriel Alvarado, Norma Susana Chávez Villagómez, Alberto Dario Díaz Parra, María Fernanda Navas Espinosa
      Salud, Ciencia y Tecnología.2024; 4: 1241.     CrossRef
    • Prevalence of Thyroid Nodules and Predictive Factors for their Malignancy: Is there any Correlation between Level of TSH and Type of Malignancy?: A Cross Sectional Study
      Leila Moradi, Mohsen Hani Tabaei Zavareh, Ferdos Zaman, Anahita Shareghi Bruojeni, Seyed Amir Mohammad Taravati, Hossein Naderi Boldaji, Koushan Rostami, Seyedeh Ghazal Shahrokh
      Advanced Biomedical Research.2024;[Epub]     CrossRef
    • Research Progress on Risk Factors of Thyroid Cancer
      丽 焦
      Advances in Clinical Medicine.2024; 14(08): 400.     CrossRef
    • Relationship between Serum Levels of Selenium and Thyroid Cancer: A Systematic Review and Meta-Analysis
      Runhua Hao, Ping Yu, Lanlan Gui, Niannian Wang, Da Pan, Shaokang Wang
      Nutrition and Cancer.2023; 75(1): 14.     CrossRef
    • Oxidative stress mediates the associations between phthalate exposures and thyroid cancer/benign nodule risk
      Chong Liu, Long-Qiang Wang, Min Zhang, Yan-Ling Deng, Qiong Luo, Er-Nan Liu, Pan-Pan Chen, Yu Miao, Pan Yang, Qiang Zeng
      Environmental Pollution.2023; 326: 121462.     CrossRef
    • Selenium and thyroid diseases
      Fei Wang, Chunyu Li, Shaoxin Li, Lili Cui, Junyu Zhao, Lin Liao
      Frontiers in Endocrinology.2023;[Epub]     CrossRef
    • Preoperative evaluation of thyroid nodules – Diagnosis and management strategies
      Tapoi Dana Antonia, Lambrescu Ioana Maria, Gheorghisan-Galateanu Ancuta-Augustina
      Pathology - Research and Practice.2023; 246: 154516.     CrossRef
    • Evaluation of Thyroid Fine Needle Aspiration Biopsy Results: A Single Center Experience
      Baris KARAGÜN
      Acta Medica Alanya.2023; 7(1): 34.     CrossRef
    • Thyroid Nodules and Obesity
      Elpida Demetriou, Maria Fokou, Savvas Frangos, Panagiotis Papageorgis, Panayiotis A. Economides, Aliki Economides
      Life.2023; 13(6): 1292.     CrossRef
    • Per- and polyfluoroalkyl substances and the associated thyroid cancer risk: A case-control study in China
      Haoran Li, Ming Yang, Jing Yang, Samuel Seery, Chaoying Ma, Yi Liu, Xiaoguang Zhang, Ang Li, Huicai Guo
      Chemosphere.2023; 337: 139411.     CrossRef
    • Interaction between Genetic Risks and Socioeconomic Factors on Thyroid Cancer: Evidence from 0.5 Million UK Biobank Participants
      Yu Li, Yongle Zhan, Wei Mao, Baoxin Wang, Pin Dong, Rong Na
      Cancers.2023; 15(20): 5028.     CrossRef
    • Thyroid Cancer Diagnostics Related to Occupational and Environmental Risk Factors: An Integrated Risk Assessment Approach
      Gabriela Maria Berinde, Andreea Iulia Socaciu, Mihai Adrian Socaciu, Andreea Cozma, Armand Gabriel Rajnoveanu, Gabriel Emil Petre, Doina Piciu
      Diagnostics.2022; 12(2): 318.     CrossRef
    • Ferroptosis-Related APOE, BCL3 and ALOX5AP Gene Polymorphisms are Associated with the Risk of Thyroid Cancer
      Zhifu Xiao, Haixia Zhao
      Pharmacogenomics and Personalized Medicine.2022; Volume 15: 157.     CrossRef
    • The Effect of Gout on Thyroid Cancer Incidence: A Nested Case-Control Study Using a National Health Screening Cohort
      So Young Kim, Dae Myoung Yoo, Mi Jung Kwon, Ji Hee Kim, Joo-Hee Kim, Woo Jin Bang, Sung Kyun Kim, Hyo Geun Choi
      Journal of Personalized Medicine.2022; 12(6): 887.     CrossRef
    • Seaweed and Iodine Intakes and SLC5A5 rs77277498 in Relation to Thyroid Cancer
      Tung Hoang, Eun Kyung Lee, Jeonghee Lee, Yul Hwangbo, Jeongseon Kim
      Endocrinology and Metabolism.2022; 37(3): 513.     CrossRef
    • Thyroid Diseases and Thyroid Asymptomatic Dysfunction in People Living With HIV
      Cristina Micali, Ylenia Russotto, Benedetto Maurizio Celesia, Laura Santoro, Andrea Marino, Giovanni Francesco Pellicanò, Giuseppe Nunnari, Emmanuele Venanzi Rullo
      Infectious Disease Reports.2022; 14(5): 655.     CrossRef
    • Thyroid Cancer and Psoriasis: A Nested Case–Control Study
      So Young Kim, Dae Myoung Yoo, Juyong Chung, Hyo Geun Choi
      Diagnostics.2022; 12(10): 2297.     CrossRef
    • Association between Obesity Indexes and Thyroid Cancer Risk in Korean Women: Nested Case–Control Study
      Yoonyoung Jang, Taehwa Kim, Brian H. S. Kim, Boyoung Park
      Cancers.2022; 14(19): 4712.     CrossRef
    • Relationship Between Physical Activity Levels and Thyroid Cancer Risk: A Prospective Cohort Study in Korea
      Anh Quynh Bui, Madhawa Gunathilake, Jeonghee Lee, Eun Kyung Lee, Jeongseon Kim
      Thyroid.2022; 32(11): 1402.     CrossRef
    • Association Between Genetic Risk, Adherence to Healthy Lifestyle Behavior, and Thyroid Cancer Risk
      Xiuming Feng, Fei Wang, Wenjun Yang, Yuan Zheng, Chaoqun Liu, Lulu Huang, Longman Li, Hong Cheng, Haiqing Cai, Xiangzhi Li, Xing Chen, Xiaobo Yang
      JAMA Network Open.2022; 5(12): e2246311.     CrossRef
    • Insufficient iodine nutrition may affect the thyroid cancer incidence in China
      Lijun Fan, Fangang Meng, Yunyan Gao, Peng Liu
      British Journal of Nutrition.2021; 126(12): 1852.     CrossRef
    • Thyroid cancer and its associated factors: A population‐based case‐control study
      Mohammad Taher Parad, Mohammad Fararouei, Ali Reza Mirahmadizadeh, Sima Afrashteh
      International Journal of Cancer.2021; 149(3): 514.     CrossRef
    • Evaluation of the relationship between previous statin use and thyroid cancer using Korean National Health Insurance Service-Health Screening Cohort data
      So Young Kim, Young Shin Song, Jee Hye Wee, Chanyang Min, Dae Myoung Yoo, Chang-Ho Lee, Chang Myeon Song, Bumjung Park, Hyo Geun Choi
      Scientific Reports.2021;[Epub]     CrossRef
    • Association among Body Mass Index, Genetic Variants of FTO, and Thyroid Cancer Risk: A Hospital-Based Case-Control Study of the Cancer Screenee Cohort in Korea
      Tung Hoang, Dayoung Song, Jeonghee Lee, Eun Kyung Lee, Yul Hwangbo, Jeongseon Kim
      Cancer Research and Treatment.2021; 53(3): 857.     CrossRef
    • Reproductive and menstrual factors for papillary thyroid cancer risk: A case-control study in Chinese women
      Jia-liu He, Chi Zhang, Ming-jun Hu, Hua-bing Wu, Xue-lei Lu, Jia-hu Hao, Fen Huang
      Cancer Epidemiology.2021; 73: 101964.     CrossRef
    • Advanced thyroid carcinomas: neural network analysis of ultrasonographic characteristics
      Michael Cordes, Theresa Ida Götz, Elmar Wolfgang Lang, Stephan Coerper, Torsten Kuwert, Christian Schmidkonz
      Thyroid Research.2021;[Epub]     CrossRef
    • Effect of Cigarette Smoking on Thyroid Cancer: Meta-Analysis
      Joon-Hyop Lee, Young Jun Chai, Ka Hee Yi
      Endocrinology and Metabolism.2021; 36(3): 590.     CrossRef
    • Epidemiologic, Clinical, Ultrasonographic, and Cytological Features of Thyroid Nodules in Predicting Malignancy Risk: A Retrospective Study of 442 French Afro-Caribbean Patients
      Johan Joseph-Auguste, Lucien Lin, Magalie Demar, Olivier Duffas, Vincent Molinie, Caroline Sulpicy, Marie-Josée Dorival, Olivier Luxembourger, Nadia Sabbah
      International Journal of Endocrinology.2020; 2020: 1.     CrossRef
    • Serous BMP8A has Clinical Significance in the Ultrasonic Diagnosis of Thyroid Cancer and Promotes Thyroid Cancer Cell Progression
      Kun Liu, Min Gao, Dongdong Qin, Hongjun Wang, Qixiu Lu
      Endocrine, Metabolic & Immune Disorders - Drug Targets.2020; 20(4): 591.     CrossRef
    • Association between Family Histories of Thyroid Cancer and Thyroid Cancer Incidence: A Cross-Sectional Study Using the Korean Genome and Epidemiology Study Data
      Soo-Hwan Byun, Chanyang Min, Hyo-Geun Choi, Seok-Jin Hong
      Genes.2020; 11(9): 1039.     CrossRef
    • Obesity is positively related and tobacco smoking and alcohol consumption are negatively related to an increased risk of thyroid cancer
      Soo-Youn An, So Young Kim, Dong Jun Oh, Chanyang Min, Songyoung Sim, Hyo Geun Choi
      Scientific Reports.2020;[Epub]     CrossRef
    • Radiation and Second Primary Thyroid Cancer Following Index Head and Neck Cancer
      Katherine M. Polednik, Matthew C. Simpson, Eric Adjei Boakye, Kahee A. Mohammed, John J. Dombrowski, Mark A. Varvares, Nosayaba Osazuwa‐Peters
      The Laryngoscope.2019; 129(4): 1014.     CrossRef
    • Active and Passive Smoking, BRAFV600E Mutation Status, and the Risk of Papillary Thyroid Cancer: A Large-Scale Case-Control and Case-Only Study
      Kyoung-Nam Kim, Yunji Hwang, Kyungsik Kim, Kyu Eun Lee, Young Joo Park, June Young Choi, Do Joon Park, BeLong Cho, Daehee Kang, Sue K. Park
      Cancer Research and Treatment.2019; 51(4): 1392.     CrossRef
    • Association of obesity with the clinicopathological features of thyroid cancer in a large, operative population
      Sitong Zhao, Xiaomeng Jia, Xiaojing Fan, Ling Zhao, Ping Pang, Yajing Wang, Yukun Luo, Fulin Wang, Guoqing Yang, Xianling Wang, Weijun Gu, Li Zang, Yu Pei, Jin Du, Jianming Ba, Jingtao Dou, Yiming Mu, Zhaohui Lyu
      Medicine.2019; 98(50): e18213.     CrossRef
    • Bethesda thyroid categories and family history of thyroid disease
      D. Kust, J. Staničić, N. Mateša
      Clinical Endocrinology.2018; 88(3): 468.     CrossRef
    • Thyroid cancer among female workers in Korea, 2007–2015
      Seonghoon Kang, Jinho Song, Taehwan Koh, One Park, Jong-Tae Park, Won-Jin Lee
      Annals of Occupational and Environmental Medicine.2018;[Epub]     CrossRef
    • Cigarette smoking and thyroid cancer risk: a cohort study
      Ara Cho, Yoosoo Chang, Jiin Ahn, Hocheol Shin, Seungho Ryu
      British Journal of Cancer.2018; 119(5): 638.     CrossRef
    • Interplay between Body Size Measures and Thyroid Cancer Aggressiveness: A Retrospective Analysis
      Thaís Gomes de Melo, Ligia Vera Montali da Assumpção, Denise Engelbrecht Zantut-Wittmann
      International Journal of Endocrinology.2018; 2018: 1.     CrossRef
    • Genetic variations in TAS2R3 and TAS2R4 bitterness receptors modify papillary carcinoma risk and thyroid function in Korean females
      Jeong-Hwa Choi, Jeonghee Lee, Sarah Yang, Eun Kyung Lee, Yul Hwangbo, Jeongseon Kim
      Scientific Reports.2018;[Epub]     CrossRef
    • The Relationship Between Human Development Index and Its Components with Thyroid Cancer Incidence and Mortality: Using the Decomposition Approach
      Mokhtar Soheylizad, Salman Khazaei, Ensiyeh Jenabi, Ali Delpisheh, Yousef Veisani
      International Journal of Endocrinology and Metabolism.2018;[Epub]     CrossRef
    • Modern view on the risk factors for malignant tumors of the thyroid gland: a systematic review
      В. І. Ткаченко, Я. Ю. Рімар
      Family medicine.2018; (3): 57.     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Risk Factors for Thyroid Cancer: A Hospital-Based Case-Control Study in Korean Adults
      Cancer Res Treat. 2017;49(1):70-78.   Published online June 23, 2016
      Close
    • XML DownloadXML Download
    Risk Factors for Thyroid Cancer: A Hospital-Based Case-Control Study in Korean Adults
    Risk Factors for Thyroid Cancer: A Hospital-Based Case-Control Study in Korean Adults
    Variable Controla) (n=802) Case (n=802) Crude OR (95% CI) Adjusted OR (95% CI)b)
    Sex
     Male 432 (53.9) 229 (28.6) 1.00 1.00
     Female 370 (46.1) 573 (71.5) 2.97 (2.38-3.71) 2.08 (1.26-3.45)
    BMI (kg/m2)
     < 23 307 (38.3) 309 (38.5) 1.00 1.00
     23-25 218 (27.2) 221 (27.6) 1.01 (0.79-1.29) 1.21 (0.85-1.72)
     > 25 277 (34.5) 272 (33.9) 0.98 (0.77-1.23) 1.23 (0.88-1.72)
    Family history of cancerc)
     No 211 (26.3) 246 (30.7) 1.00 1.00
     Yes 585 (72.9) 543 (67.7) 0.79 (0.63-0.99) 0.74 (0.54-1.02)
     Missing 6 (0.8) 13 (1.6)
    Family history of thyroid cancerc)
     No 785 (97.9) 748 (93.3) 1.00 1.00
     Yes 11 (1.4) 41 (5.1) 3.64 (1.87-7.09) 4.39 (1.73-11.15)
     Missing 6 (0.8) 13 (1.6)
    Education
     Middle school or below 121 (15.1) 139 (17.3) 1.00 1.00
     High school 263 (32.8) 260 (32.4) 0.82 (0.60-1.12) 1.06 (0.66-1.69)
     College or above 409 (51.0) 350 (43.6) 0.67 (0.49-0.92) 1.19 (0.72-1.97)
     Missing 9 (1.1) 53 (6.6)
    Occupation
     Housewife 228 (28.4) 349 (43.5) 1.00 1.00
     Profession/Office worker 329 (41.0) 229 (28.6) 0.46 (0.36-0.59) 1.11 (0.26-1.76)
     Sales/Service 122 (15.2) 100 (12.5) 0.55 (0.40-0.76) 1.07 (0.66-1.71)
     Agriculture/Laborer/Unemployed/Others 114 (14.2) 80 (10.0) 0.47 (0.32-0.66) 0.99 (0.56-1.76)
     Missing 9 (1.1) 44 (5.5)
    Monthly household income
     < $1,853d) 82 (10.2) 107 (13.3) 1.00 1.00
     $1,853-$3,706 221 (27.6) 224 (27.9) 0.65 (0.44-0.97) 0.72 (0.44-1.19)
     > $3,706 429 (53.5) 329 (41.0) 0.49 (0.33-0.71) 0.59 (0.36-0.98)
     Missing 70 (8.7) 142 (17.7)
    Marital status
     Married 741 (92.4) 674 (84.0) 1.00 1.00
     Unmarried 26 (3.2) 25 (3.1) 1.01 (0.55-1.87) 0.70 (0.31-1.62)
     Divorced/Widowed 35 (4.4) 74 (9.2) 2.38 (1.54-3.67) 1.67 (0.87-3.22)
     Missing 0 29 (3.6)
    Alcohol consumption
     Non-drinker 236 (29.4) 360 (44.9) 1.00 1.00
     Former drinker 30 (3.7) 45 (5.6) 1.05 (0.63-1.76) 1.79 (0.87-3.71)
     Current drinker 520 (64.8) 373 (46.5) 0.46 (0.36-0.57) 0.92 (0.66-1.30)
     Ever-drinker 550 (49.0) 418 (25.7) 0.50 (0.40-0.61) 0.81 (0.63-1.06)
     Missing 16 (2.0) 24 (3.0)
    Smoking status
     Non-smoker 382 (47.6) 547 (68.2) 1.00 1.00
     Former smoker 178 (22.2) 109 (13.6) 0.43 (0.33-0.58) 0.75 (0.48-1.17)
     Current smoker 215 (26.8) 97 (12.1) 0.29 (0.22-0.40) 0.49 (0.31-0.78)
     Ever-smoker 393 (49.0) 206 (25.7) 0.34 (0.27-0.43) 0.62 (0.44-0.86)
     Missing 27 (3.4) 49 (6.1)
    Variable Control (n=802) Case (n=802) Crude OR (95% CI) Adjusted OR (95% CI)a)
    Age at starting to smoke
     Never smoking 382 (47.6) 547 (68.2) 1.00 1.00
     ≤ 18 74 (9.2) 31 (3.9) 0.26 (0.17-0.42) 0.52 (0.29-0.93)
     19-24 223 (27.8) 121 (15.1) 0.36 (0.28-0.48) 0.76 (0.52-1.12)
     ≥ 25 54 (6.7) 28 (3.5) 0.38 (0.23-0.62) 0.57 (0.33-1.01)
     Missing 69 (8.6) 75 (9.4)
     p-value for trend < 0.001 0.133
    Years of cigarette smoking
     Never smoking 382 (47.6) 547 (68.2) 1.00 1.00
     ≤ 10 40 (5.0) 34 (4.2) 0.60 (0.37-0.99) 0.87 (0.50-1.50)
     11-20 122 (15.2) 58 (7.2) 0.33 (0.23-0.47) 0.61 (0.39-0.95)
     21-30 128 (16.0) 62 (7.7) 0.30 (0.20-0.43) 0.59 (0.37-0.95)
     > 30 71 (8.9) 29 (3.6) 0.29 (0.18-0.47) 0.62 (0.35-1.10)
     Missing 59 (7.4) 72 (9.0)
     p-value for trend < 0.001 0.019
    No. of cigarettes/day
     Never smoking 382 (47.6) 547 (68.2) 1.00 1.00
     ≤ 10 110 (13.7) 58 (7.2) 0.35 (0.25-0.50) 0.61 (0.40-0.93)
     11-20 180 (22.4) 101 (12.6) 0.39 (0.29-0.52) 0.84 (0.56-1.26)
     21-30 48 (6.0) 16 (2.0) 0.23 (0.12-0.41) 0.42 (0.22-0.82)
     > 30 25 (3.1) 11 (1.4) 0.27 (0.13-0.56) 0.61 (0.26-1.42)
     Missing 57 (7.1) 69 (8.6)
     p-value for trend < 0.001 0.071
    Variable Controla) (n=802) Case (n=802) Crude OR (95% CI) Adjusted OR (95% CI)b)
    Sex
     Male 229 (28.6) 229 (28.6) - -
     Female 573 (71.5) 573 (71.5) - -
    BMI (kg/m2)
     < 23 353 (44.0) 309 (38.5) 1.00 1.00
     23-25 225 (28.1) 221 (27.6) 1.14 (0.89-1.46) 1.28 (0.98-1.68)
     > 25 224 (27.9) 272 (33.9) 1.11 (1.11-1.80) 1.42 (1.09-1.85)
    Family history of cancerc)
     No 187 (23.3) 246 (30.7) 1.00 1.00
     Yes 606 (75.6) 543 (67.7) 0.66 (0.52-0.83) 0.63 (0.49-0.81)
     Missing 9 (1.1) 13 (1.6)
    Family history of thyroid cancerc)
     No 787 (98.1) 748 (93.3) 1.00 1.00
     Yes 6 (0.8) 41 (5.1) 8.00 (3.16-20.27) 9.41 (3.61-24.51)
     Missing 9 (1.1) 13 (1.6)
    Education
     Middle school or below 159 (19.8) 139 (17.3) 1.00 1.00
     High school 276 (34.4) 260 (32.4) 1.08 (0.80-1.45) 1.19 (0.86-1.66)
     College or above 353 (44.0) 350 (43.6) 1.15 (0.85-1.57) 1.29 (0.90-1.86)
     Missing 14 (1.8) 53 (6.6)
    Occupation
     Housewife 344 (42.9) 349 (43.5) 1.00 1.00
     Profession/Office worker 229 (28.6) 229 (28.6) 0.94 (0.70-1.24) 0.87 (0.63-1.20)
     Sales/Service 113 (14.1) 100 (12.5) 0.84 (0.61-1.17) 0.77 (0.53-1.10)
     Agriculture/Laborer/Unemployed/Others 101 (12.6) 80 (10.0) 0.75 (0.53-1.07) 0.69 (0.47-1.02)
     Missing 15 (1.9) 44 (5.5)
    Monthly household income
     < $1,853d) 103 (12.8) 107 (13.3) 1.00 1.00
     $1,853-$3,706 215 (26.8) 224 (27.9) 0.99 (0.71-1.38) 0.95 (0.66-1.39)
     > $3,706 389 (48.5) 329 (41.0) 0.79 (0.57-1.08) 0.71 (0.49-1.03)
     Missing 95 (11.9) 142 (17.7)
    Marital status
     Married 710 (88.5) 674 (84.0) 1.00 1.00
     Unmarried 20 (2.5) 25 (3.1) 1.33 (0.72-2.44) 1.31 (0.68-2.50)
     Divorced/Widowed 70 (8.7) 74 (9.2) 1.21 (0.84-1.75) 1.25 (0.84-1.86)
     Missing 2 (0.3) 29 (3.6)
    Alcohol consumption
     Non-drinker 298 (37.2) 360 (44.9) 1.00 1.00
     Former drinker 34 (4.2) 45 (5.6) 1.06 (0.66-1.71) 1.13 (0.68-1.88)
     Current drinker 455 (56.7) 373 (46.5) 0.61 (0.48-0.78) 0.64 (0.49-0.82)
     Ever-drinker 489 (61.0) 418 (25.7) 1.21 (0.62-2.35) 0.68 (0.53-0.87)
     Missing 15 (1.9) 24 (3.0)
    Smoking status
     Non-smoker 541 (67.5) 547 (68.2) 1.00 1.00
     Former smoker 104 (13.0) 109 (13.6) 0.97 (0.66-1.45) 0.97 (0.63-1.48)
     Current smoker 114 (14.2) 97 (12.1) 0.79 (0.55-1.13) 0.82 (0.55-1.22)
     Ever-smoker 218 (27.2) 206 (25.7) 0.86 (0.63-1.19) 0.88 (0.62-1.25)
     Missing 43 (5.4) 49 (6.1)
    Table 1. General characteristics of the study participants with the control group 1 in univariate analysis and multivariate conditional logistic regression analysis

    OR, odds ratio; CI, confidence interval; BMI, body mass index.

    Matched to cases by age (within 2 years) and residential areas,

    Adjusted for BMI, family history of cancer, family history of thyroid cancer, education, occupation, monthly household income, marital status, alcohol consumption, and smoking status; R2=0.1277,

    First degree relatives,

    $1=1,079 Korean won (as of April 26, 2015).

    Table 2. Association between the risk of thyroid cancer and smoking history, such as age at starting to smoke, years of cigarette smoking, and number of daily cigarette smoking in multivariate conditional logistic regression analysis

    OR, odds ratio; CI, confidence interval.

    Adjusted for sex, body mass index, family history of cancer, family history of thyroid cancer, education, occupation, monthly household income, marital status, smoking status, and alcohol consumption; R2=0.1070.

    Table 3. General characteristics of the study participants with the control group 2 in univariate analysis and multivariate conditional logistic regression analysis

    OR, odds ratio; CI, confidence interval; BMI, body mass index.

    Matched to cases by age (within 2 years), residential areas, and sex,

    Adjusted for BMI, family history of cancer, family history of thyroid cancer, education, occupation, monthly household income, marital status, alcohol consumption, and smoking status; R2=0.0711,

    First degree relatives,

    $1=1,079 Korean won (as of April 26, 2015).


    Cancer Res Treat : Cancer Research and Treatment
    Close layer
    TOP